Skip to main content

Table 2 Disease activity assessment of nine patients with ESSG score = 3

From: Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis

Patient code 15 37 43 53 65 69 89 90 93
mRSS 0 2 4 5 8 4 6 6 0
Scleredema - + + + + + + + +
Δ1Skin features - - - - + - - - -
Ulcers - - + - - - - + +
Δ1Vascular features - - - - + + + - +
Arthritis + - - - - - + - -
DLCO <80% 2 + + + + - + - + -
Δ1Cardiopulmonary features + + - + - - - - -
ESR >30 mm/h 3 + + - + - - - - -
Hypocomplementemia - - - - - - - - -
NVC pattern Active Active Active Early Early Active Active Active Active
NEMO score 7 12 3 0 3 6 19 9 39
GC score 9 3 7 2 5 3 10 11 5
Cs score 7 8 7 9 9 5 8 7 7
  1. 1Worsening in the specific involvement; 2a diffusing lung capacity for carbon monoxide below 80% of predicted value; 3an erythrocyte sedimentation rate over 30 mm/h. ESSG, European Scleroderma Study Group; mRSS, modified Rodnan skin score; DLCO, diffusing capacity; ESR, erythrocyte sedimentation rate; NVC, nailfold videocapillaroscopy; NEMO, number of micro-haemorrhages; GC, giant capillaries; Cs, capillaries.